Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method

Although it has been estimated that pandemic Influenza A H1N1/2009 has infected millions of people from April to October 2009, a more precise figure requires a worldwide large-scale diagnosis of the presence of Influenza A/H1N1/2009 antibodies within the population. Assays typically used to estimate...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 5; no. 4; p. e10176
Main Authors Alvarez, Mario M., López-Pacheco, Felipe, Aguilar-Yañez, José M., Portillo-Lara, Roberto, Mendoza-Ochoa, Gonzalo I., García-Echauri, Sergio, Freiden, Pamela, Schultz-Cherry, Stacey, Zertuche-Guerra, Manuel I., Bulnes-Abundis, David, Salgado-Gallegos, Johari, Elizondo-Montemayor, Leticia, Hernández-Torre, Martín
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 14.04.2010
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Although it has been estimated that pandemic Influenza A H1N1/2009 has infected millions of people from April to October 2009, a more precise figure requires a worldwide large-scale diagnosis of the presence of Influenza A/H1N1/2009 antibodies within the population. Assays typically used to estimate antibody titers (hemagglutination inhibition and microneutralization) would require the use of the virus, which would seriously limit broad implementation. An ELISA method to evaluate the presence and relative concentration of specific Influenza A/H1N1/2009 antibodies in human serum samples is presented. The method is based on the use of a histidine-tagged recombinant fragment of the globular region of the hemagglutinin (HA) of the Influenza A H1N1/2009 virus expressed in E. coli. The ELISA method consistently discerns between Inf A H1N1 infected and non-infected subjects, particularly after the third week of infection/exposure. Since it does not require the use of viral particles, it can be easily and quickly implemented in any basic laboratory. In addition, in a scenario of insufficient vaccine availability, the use of this ELISA could be useful to determine if a person has some level of specific antibodies against the virus and presumably at least partial protection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
Conceived and designed the experiments: MMA FLP JMAY SGE SSC LEM MHT. Performed the experiments: FLP JMAY RPL GIMO SGE PF DBA JSG. Analyzed the data: MMA FLP SSC MIZG MHT. Contributed reagents/materials/analysis tools: MMA SSC MIZG LEM MHT. Wrote the paper: MMA MHT.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0010176